Q&A: Supporting Ongoing Insulin Use Through Pharmacy Counseling
Drug Topics
JULY 22, 2025
Pharmacists play a key role in monitoring insulin use by addressing dosing, storage, and symptom management through regular, supportive patient check-ins.
Drug Topics
JULY 22, 2025
Pharmacists play a key role in monitoring insulin use by addressing dosing, storage, and symptom management through regular, supportive patient check-ins.
European Pharmaceutical Review
JULY 22, 2025
Sanofi has agreed to acquire the biotech Vicebio for an upfront payment of $1.15 billion, supporting the advancement of respiratory virus vaccines. In addition to the initial payment, Sanofi will pay up to $450 million, subject to achieved development and regulatory milestones. The deal intends to expand capabilities in vaccine design and development and will enable Sanofi to add a non-mRNA vaccine to its development pipeline.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharmacy Times
JULY 22, 2025
News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice in Focus: Oncology Pharmacy Practice in Focus: Health Systems Pharmacy Careers All Publications About the Publications Author Submission Submit to
Pharmaceutical Commerce
JULY 22, 2025
News News Pharma Pulse Academy Publications Partner Perspectives Webcasts Resources Conferences Conference Coverage Conference Listing Events Videos Videos Peer Exchange Podcasts Editorial Podcasts Sponsored Podcasts Subscribe Choose Specialty Brand & Product Security Brand & Product Security Brand & Product Security Brand & Product Security Business and Finance Cold Chain Cold Chain Cold Chain Cold Chain Commercial Channels Data & Technology Data & Technology Data &
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Pharmacy Times
JULY 22, 2025
News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice in Focus: Oncology Pharmacy Practice in Focus: Health Systems Pharmacy Careers All Publications About the Publications Author Submission Submit to
Pharma Times
JULY 22, 2025
Subscribe Advertise About us Follow Follow Follow Follow GO Magazine PharmaTimes Magazine Archive Web Exclusives News Competitions Appointments Business Insights Webinars Thought Leadership PhoreMost unveils platform to streamline molecular glue drug discovery by John Pinching | 22nd Jul 2025 | News GlueSEEKER enables rational design of targeted protein degraders PhoreMost has published new data validating its GlueSEEKER platform, a high-throughput technology designed to accelerate molecular glu
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Drug Topics
JULY 22, 2025
News FDA Updates Law and Advocacy Technology Trends Viewpoints All News Media In-Depth Insights Pharmacist View Script-Ed Expert Interviews Podcasts Conferences Conference Coverage Conference Listing Resources Disease Awareness White Board Video American Pharmacists Month Sponsored Resources CME/CE Partners Publications Drug Topics Journal Total Pharmacy Journal Submission of Articles Events Virtual Events Total Pharmacy Solutions Summit Business Business Strategies Patient Services Pharmacy Inv
Pharmacy Times
JULY 22, 2025
News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice in Focus: Oncology Pharmacy Practice in Focus: Health Systems Pharmacy Careers All Publications About the Publications Author Submission Submit to
Drug Topics
JULY 22, 2025
Flu vaccination significantly reduces illness in both vaccinated and unvaccinated individuals, highlighting its importance in public health strategies.
Pharmacy Times
JULY 22, 2025
News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice in Focus: Oncology Pharmacy Practice in Focus: Health Systems Pharmacy Careers All Publications About the Publications Author Submission Submit to
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Drug Topics
JULY 22, 2025
In part 4 of our interview with Michael Kleinrock, lead director of research at IQVIA, he discussed how trends in medication use are currently impacting pharmacy businesses.
Pharmacy Times
JULY 22, 2025
News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice in Focus: Oncology Pharmacy Practice in Focus: Health Systems Pharmacy Careers All Publications About the Publications Author Submission Submit to
PharmaShots
JULY 22, 2025
Shots: The EMA’s CHMP has granted positive opinions and approvals to 2 Biologics and 6 new chemical entities in June 2025, leading to treatments for patients and advances in the healthcare industry The major highlighted drug was SpringWorks Therapeutics’ Ogsiveo to Treat Desmoid Tumours PharmaShots has compiled a list of 8 drugs that have been granted positive opinions and approvals by the EC, respectively Italfarmaco Obtains the EC’s Conditional Approval for Duvyzat to Treat Duchenne Muscul
Pharmacy Times
JULY 22, 2025
News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice in Focus: Oncology Pharmacy Practice in Focus: Health Systems Pharmacy Careers All Publications About the Publications Author Submission Submit to
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Pharma Marketing Network
JULY 22, 2025
In the fast-paced world of healthcare communications, email remains both a relic and a revelation. Some say Pharma Marketing Email is losing relevance amid data privacy constraints and rising digital noise. Yet others argue it’s just beginning to show its full potential—especially with the rise of artificial intelligence. So, is pharma email marketing truly a dying breed or a channel reborn?
Pharmacy Times
JULY 22, 2025
From AI-powered prescription fulfillment to the expansion of PillPack for Medicare patients, Carey outlines how Amazon Pharmacy is streamlining access, improving affordability, and setting the stage for a more patient-centered health care future.
Pharmaceutical Commerce
JULY 22, 2025
In the first part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Brad Stewart, BDO’s national life sciences co-leader, describes the immediate and long-term impacts of this potential levy on pharma imports.
Pharmafile
JULY 22, 2025
MetP Pharma has released new data highlighting the advantages of its MetP technology in delivering neuroactive peptides, particularly semaglutide, directly to the brain though the intranasal route. This opens up the possibility of the platform being used for a wide range of neuroactive therapeutics, from metabolic to neurodegenerative diseases. The data demonstrates that the MetP […] The post MetP Pharma releases positive data on intranasal semaglutide administration appeared first on Phar
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Drug Topics
JULY 22, 2025
News FDA Updates Law and Advocacy Technology Trends Viewpoints All News Media In-Depth Insights Pharmacist View Script-Ed Expert Interviews Podcasts Conferences Conference Coverage Conference Listing Resources Disease Awareness White Board Video American Pharmacists Month Sponsored Resources CME/CE Partners Publications Drug Topics Journal Total Pharmacy Journal Submission of Articles Events Virtual Events Total Pharmacy Solutions Summit Business Business Strategies Patient Services Pharmacy Inv
Pharmacy Times
JULY 22, 2025
UPMC Health Plan enhances COPD care through a multidisciplinary approach, leveraging telehealth, education, and pharmacist-led programs to optimize patient outcomes.
Pharmaceutical Technology
JULY 22, 2025
Skip to site menu Skip to page content Switch language: translate --> PT Menu Search Sections Home News Analysis Features Comment & Opinion Projects Data Insights Sectors Clinical Trials Drug Manufacturers Therapy Area Cardiovascular Central Nervous System Immunology Infectious Disease Oncology Respiratory Pricing and Market Access Themes Artificial Intelligence Corporate Governance Cloud Cybersecurity Environmental Sustainability Internet of Things Robotics Social Responsibility Covid-19 Insigh
Pharmacy Times
JULY 22, 2025
Results from the ZENITH trial show sotatercept's promise for pulmonary arterial hypertension treatment.
PharmaShots
JULY 22, 2025
Shots: The EC has approved Itovebi + Ibrance & fulvestrant as a 1L therapy for adults with PIK3CA-mutated, ER+/HER2- locally advanced or metastatic breast cancer recurring on or within 12mos. of adj. endocrine therapy, based on the P-III ( INAVO120 ) trial Trial (n=325) assessed the regimen vs PBO + Ibrance & fulvestrant, which showed improved PFS (1EP) by 57% (mPFS: 15 vs 7.3mos.) & a 33% reduction in death risk, with consistent PFS benefit across subgroups; regimen delayed also CT
Drug Topics
JULY 22, 2025
With an emphasis on the factors that differentiate the future roles of pharmacists, researchers sought to better understand the career intentions of pharmacy students.
PhRMA
JULY 22, 2025
Lawmakers promised that the Inflation Reduction Act (IRA) would make prescription drugs more affordable. But a new analysis from the USC Schaeffer Center shows that most Medicare beneficiaries could see higher out-of-pocket costs under the law.
Pharma Marketing Network
JULY 22, 2025
AstraZeneca is making headlines again, this time with an ambitious $50 billion investment plan targeting the U.S. market. But what does this move signify for the pharmaceutical landscape, and more importantly, for American patients and healthcare providers? Think of it as a high-stakes chess match where AstraZeneca is positioning its knights, rooks, and queens with strategic intent, aiming to dominate key therapeutic areas and reshape the U.S. pharma market.
The Checkup by Singlecare
JULY 22, 2025
Buprenorphine is a partial opioid agonist and is used to treat pain. Brand names for buprenorphine include Buprenex, Simbadol, and Belbuca. Buprenorphine is FDA approved for use in humans and cats , but not dogs. However, veterinarians often prescribe it off-label for dogs. Buprenorphine for dogs is used primarily to treat pain after surgeries or to treat certain chronic conditions that cause pain.
Pharmaceutical Technology
JULY 22, 2025
Skip to site menu Skip to page content Switch language: translate --> PT Menu Search Sections Home News Analysis Features Comment & Opinion Projects Data Insights Sectors Clinical Trials Drug Manufacturers Therapy Area Cardiovascular Central Nervous System Immunology Infectious Disease Oncology Respiratory Pricing and Market Access Themes Artificial Intelligence Corporate Governance Cloud Cybersecurity Environmental Sustainability Internet of Things Robotics Social Responsibility Covid-19 Insigh
PharmaVoice
JULY 22, 2025
Skip to main content CONTINUE TO SITE âžž Dont miss the most important voices in pharma Let PharmaVoices free newsletter keep you informed on what industry leaders are saying, straight from your inbox. By signing up to receive our newsletter, you agree to our Terms of Use and Privacy Policy. You can unsubscribe at anytime. Voices Q&A Profiles Biotech Spotlight First 90 Days Opinions Topics Biotech Commercialization Leadership Manufacturing Patient Pharma Policy & Regulation Research & Deve
PharmTech
JULY 22, 2025
News All News Bio/Pharma News Publications All Publications PharmTech PharmTech Europe Resources Marketplace ICH Q9 Revision: A Comprehensive Resource on Quality Risk Management Peer-Reviewed Research PharmTech Products Pharma Insights Sponsored Podcasts Sponsored Videos Sponsored eBooks Whitepapers Webcasts Multimedia All Videos Ask the Expert Behind The Headlines Buy, Sell, Hold Drug Digest Videos Drug Solutions Podcast Peer Exchange Sexy Science Tech Talk Conference Conference Coverage Confer
PhRMA
JULY 22, 2025
This week, PhRMA re-launched Innovation.org – a platform that tells the story of the biopharmaceutical industry’s progress, transformative innovation and commitment to America’s patients, workers and communities.
Pharmaceutical Commerce
JULY 22, 2025
In the first part of his Pharma Commerce video interview, Hyung Heon Kim, CEO of MetaVia, describes the US payer ecosystem’s level of preparedness to support broader access and long-term affordability for these therapies.
Pharmacy Times
JULY 22, 2025
The complete response letter (CRL) did not raise safety concerns, but stated the IGNYTE trial was inadequate and did not provide substantial evidence of effectiveness.
Let's personalize your content